Search

Gyongyi Szabo, MD, PhD, FAASLD, AGAF, FACP Mitchell T. Rabkin, M.D. Chair Professor of Medicine and Faculty Dean for Academic Affairs Harvard Medical School Chief Academic Officer Beth Israel Lahey Health and Beth Israel Deaconess Medical Center Email: gszabo1@bidmc.harvard.edu Shauntae M. Wilson...

In our laboratory, we study mechanisms of innate immune activation in liver diseases and its role on modulation of liver parenchymal cells including hepatocytes and stellate cells. We employ a broad range of preclinical murine liver injury models of alcoholic hepatitis, non-alcoholic steatohepatitis...

Biomarkers in Liver Disease We are exploring novel therapies and biomarker discoveries in AH. Direct effects of alcohol on hepatocytes, increased intestinal permeability and activation of innate immune system (Kupffer cells) by gut-derived LPS are major factors in AH leading to over-activation of...

Coming soon Selected Publications: Marti et al. publication Zhuang Y, Ortega-Ribera M, Nagesh PT, Joshi R, Huang H, Wang Y, Zivny A, Mehta J, Parikh SM, Szabo G. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney...